Cambridge Investment Research Advisors
NVAX icon

Cambridge Investment Research Advisors’s Novavax NVAX Stock Holding History

Cambridge Investment Research Advisors’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-15,175
Closed -$73K – 3398
2024
Q1 		$73K Sell
15,175
-4,057
-21% -$18.8K ﹤0.01% 3182
2023
Q4 		$92K Sell
19,232
-9,996
-34% -$61.2K ﹤0.01% 3048
2023
Q3 		$212K Buy
+29,228
New +$234K ﹤0.01% 2769
2023
Q2 		– Sell
-12,432
Closed -$86K – 3256
2023
Q1 		$86K Buy
+12,432
New +$114K ﹤0.01% 2981
2022
Q4 		– Sell
-10,294
Closed -$187K – 3182
2022
Q3 		$187K Sell
10,294
-8,419
-45% -$365K ﹤0.01% 2720
2022
Q2 		$962K Buy
18,713
+4,272
+30% +$221K 0.01% 1505
2022
Q1 		$1.06M Buy
14,441
+2,609
+22% +$233K ﹤0.01% 1537
2021
Q4 		$1.69M Buy
11,832
+3,313
+39% +$569K 0.01% 1242
2021
Q3 		$1.77M Buy
8,519
+613
+8% +$135K 0.01% 1166
2021
Q2 		$1.68M Buy
7,906
+1,845
+30% +$338K 0.01% 1212
2021
Q1 		$1.1M Sell
6,061
-3,305
-35% -$659K 0.01% 1373
2020
Q4 		$1.04M Sell
9,366
-980
-9% -$104K 0.01% 1279
2020
Q3 		$1.12M Buy
10,346
+2,766
+36% +$337K 0.01% 1121
2020
Q2 		$632K Buy
+7,580
New +$290K ﹤0.01% 1417
2019
Q2 		– Sell
-878
Closed -$10K – 2302
2019
Q1 		$10K Sell
878
-185
-17% -$5.84K ﹤0.01% 2267
2018
Q4 		$39K Buy
1,063
+199
+23% +$7.71K ﹤0.01% 2100
2018
Q3 		$32K Buy
864
+53
+7% +$1.49K ﹤0.01% 2212
2018
Q2 		$22K Buy
811
+27
+3% +$913 ﹤0.01% 2189
2018
Q1 		$33K Buy
+784
New +$31.5K ﹤0.01% 2115

Other funds holding NVAX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Shah Capital Management Raleigh, North Carolina $521M AUM 46.95% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return
Voloridge Investment Management
Voloridge Investment Management Jupiter, Florida $25B AUM 28.08% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Cambridge Investment Research Advisors's NVAX Position: Q2 2024 in Review

Cambridge Investment Research Advisors sold out of Novavax (NVAX) in Q2 2024, closing a stake of 15,175 shares — an estimated $73K sold.

Cambridge Investment Research Advisors first reported a position in NVAX in Q1 2018 and held it in 19 quarters. The position peaked at $1.77M in Q3 2021. 230 funds tracked by Wall St. Rank hold NVAX as of Q2 2024.

  • Cambridge Investment Research Advisors reported no remaining Novavax position as of Q2 2024 after selling out during the quarter.
  • Cambridge Investment Research Advisors sold 15,175 Novavax shares in Q2 2024, an estimated $73K.
  • Cambridge Investment Research Advisors first reported a position in Novavax in Q1 2018 and held it in 19 quarters.
  • Cambridge Investment Research Advisors's Novavax position peaked at $1.77M in Q3 2021.
  • 230 funds tracked by Wall St. Rank held Novavax as of Q2 2024.

Based on Cambridge Investment Research Advisors's 13F filing for Q2 2024, filed 26 Jul 2024.